tradingkey.logo
tradingkey.logo
Suchen

Haleon PLC

HLN
Zur Watchlist hinzufügen
9.235USD
+0.285+3.18%
Handelsschluss 06/24, 16:00ETKurse um 15 Minuten verzögert
41.13BMarktkapitalisierung
33.52KGV TTM

mehr Informationen über Haleon PLC Unternehmen

Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.

Haleon PLC Informationen

BörsenkürzelHLN
Name des UnternehmensHaleon PLC
IPO-datumJul 18, 2022
CEOMcnamara (Brian)
Anzahl der mitarbeiter- -
WertpapierartDepository Receipt
GeschäftsjahresendeJul 18
AddresseBuilding 5, First Floor
StadtWEYBRIDGE
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited Kingdom
PostleitzahlKT13 0NY
Telefon441932822000
Websitehttps://www.haleon.com/
BörsenkürzelHLN
IPO-datumJul 18, 2022
CEOMcnamara (Brian)

Führungskräfte von Haleon PLC

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+88.56%
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Ms. Marie-Anne Aymerich
Ms. Marie-Anne Aymerich
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Manvinder Singh S. Banga ,
Mr. Manvinder Singh S. Banga ,
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dame Vivienne Cox
Dame Vivienne Cox
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Asmita Dubey
Ms. Asmita Dubey
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Amanda J. Mellor
Ms. Amanda J. Mellor
Company Secretary
Company Secretary
--
--
Mr. Keith Choy
Mr. Keith Choy
President, Asia Pacific
President, Asia Pacific
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+88.56%
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Ms. Marie-Anne Aymerich
Ms. Marie-Anne Aymerich
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Manvinder Singh S. Banga ,
Mr. Manvinder Singh S. Banga ,
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Haleon PLC?

Die fünf größten Anteilseigner von Haleon PLC sind: Ms. Lisa Paley

Wie viele Institutionen halten Anteile an Haleon PLC (HLN)?

Mit Stand vom 2026Q1 halten 1090 Institutionen Anteile an Haleon PLC, mit einem Gesamtmarktwert von etwa 575.83M, was 12.97% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 12046665.00 gestiegen.

Was ist die größte Einnahmequelle von Haleon PLC?

Am 2026Q1 erzielte das Geschäft mit Oral health für Haleon PLC den höchsten Umsatz in Höhe von 3.46B, was 31.38% des Gesamtumsatzes entspricht.
KeyAI